ResearchMoz

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

Winter Green Research
Published Date » 2013-02-11
No. Of Pages » 293

WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 293 pages, 67 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need Intraocular Lenses (IOL). All older people develop cataracts.

Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting.

Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an ever-increasing baby boom aging population. There is a growing precision of cataract surgery. Safety of cataract surgical medical devices and lenses are primary market concerns. More advanced procedures are driving an increase in cataract surgery. Lower costs per surgery are driving an increase in cataract surgery.

Cataract surgical technology is evolving rapidly. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient's post-cataract visual expectations. Laser-assisted cataract surgery technology is gaining traction with clinicians. Surgeons are getting trained in the techniques needed to perform surgeries these new types of equipment. The motivation to learn the new surgical techniques is that the equipment comes with the promise of improved surgical precision.

According to Susan Eustis, lead author of the WinterGreen Research team that prepared the Intraocular Lens (IOL) market research study, "Superior image quality brings clinical improvement. Patients are thrilled when they can see so much more clearly."

As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.

Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery. It is certain to remain the dominant lens removal technology in the near term. A technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights.

Numerous types, and styles of Intraocular Lenses (IOLs), varying in size, and attachment mechanisms. The femtosecond lasers may evolve capability to fix the cataract without implanting an IOL devices, creating a significant change in the market after the forecast period.

The eye care industry is highly competitive and subject to rapid technological change and evolving industry requirements and standards. Companies within this industry compete on technological leadership and innovation, quality and efficacy of their products, relationships with eye care professionals and healthcare providers, breadth and depth of product offering and pricing. The presence of these factors varies across regions.

In the United States, the leading market segment, an aging population, the affluence of the American "baby boomer" generation, and the ability of surgeons to bill for a premium refractive outcome will drive significant growth in this lens-based refractive surgery sector.

Intraocular Lens (IOL) markets are driven by the trend towards multi-distance vision capability, near middle, and far. The global market is expected to post a modest growth. The global market for Intraocular Lenses (IOL) total market value is expected to reach $3.8 billion by 2019.

The global intraocular lens cataract market is expanding with the aging of a more affluent middle class population. There were 19 million cataract surgeries in 2010 and 19.7 million in 2012. Cataracts account for 48% of world blindness. Cataracts are the leading cause of reversible blindness.

Companies Profiled

Market Leaders

  • Novartis / Alcon
  • Abbott Medical Optics
  • Bausch & Lomb
  • Hoya
  • Carl Zeiss Meditec AG
  • Staar Surgical
  • EuroCrystal SA
  • HumanOptics AG
  • OPHTEC BV 

Market Participants

  • Akkolens
  • Allergan
  • Aravind
  • Biovision
  • Elenza
  • Kowa Company, Ltd.
  • Lenstec
  • Novartis Group / Alcon
  • OptiMedica
  • Physiol
  • Rayner
  • Staar Surgical
  • WaveTec Vision®

Check Out These Key Topics

  • Cataract Surgery
  • Intraocular Lens (IOL)
  • Hydrophilic Collamer Ultra-High Water
  • Toric Visual Acuity
  • FDA-Approved Intraocular Lens
  • Medical Optics Cataract
  • Cataract Surgical
  • Eye Surgical Techniques
  • IOL Acrylic Material
  • Cataract Surgery
  • Ocular Surgical Guidance Technology
  • Femtosecond Technology
  • Intraocular Lens (IOL) Market Share
  • Intraocular Lens (IOL) Market Forecasts
  • IOL Market Share
  • IOL Market Forecasts
Table of Content

Intraocular Lens (IOL) Executive Summary
Intraocular Lens Market Driving Forces
Cataract Surgical Technology Is Evolving Rapidly
Patient Populations Have Significant Demand for Cataract Surgery
Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
Cataract Surgery Business
Intraocular Lens Market Challenges
World Population Growth
Intraocular Lens Market Shares
Intraocular Lens Market Forecasts

1. Intraocular Lens Market Description and Market Dynamics
1.1 Cataract Surgical Technology Is Evolving Rapidly
1.1.1 Patient Populations Have Significant Demand for Cataract Surgery
1.1.2 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
1.1.3 Cataract Surgery Business
1.1.4 Intraocular Lens Market Challenges
1.2 World Economy Undergoing A Transformation
1.2.1 Global Economic Conditions:
1.2.2 Global Economy Becomes Steadily More Sluggish
1.2.3 Global Economic Conditions Impact Markets

2. Intraocular Lens Market Shares and Forecasts
2.1 Intraocular Lens Market Driving Forces
2.1.1 Cataract Surgical Technology Is Evolving Rapidly
2.1.2 Patient Populations Have Significant Demand for Cataract Surgery
2.1.3 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
2.1.4 Cataract Surgery Business
2.1.5 Intraocular Lens Market Challenges
2.1.6 World Population Growth
2.2 Intraocular Lens Market Shares
2.2.1 Novartis / Alcon
2.2.2 Novartis / Alcon Competitive Situation
2.2.3 Novartis / Alcon Competition
2.2.4 Novartis Alcon Multifocal Lenses
2.2.5 Novartis / Alcon
2.2.6 Novartis / Alcon
2.2.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.2.8 LenSx Acquired by Alcon
2.2.9 Abbott Medical Optics
2.2.10  Abbott Medical Optics / Visiogen’s Synchrony
2.2.11  Abbott Tecnis
2.2.12  Abbott TECNIS® IOLs
2.2.13  Bausch & Lomb Presbyopic IOLs
2.2.14  Bausch + Lomb
2.2.15  Bausch + Lomb Eye Surgical Technologies In The Pipeline
2.2.16  Bausch + Lomb: Accommodating IOLs
2.2.17  Bausch + Lomb:  Crystalens IOL
2.2.18  OptiMedica
2.2.19  Staar Acrylic IOL
2.2.20  Staar
2.2.21  Staar Silicone IOLs
2.2.22  Staar® Surgical Company nanoFLEX IOL
2.2.23  Staar Visian
2.2.24  LensAR
2.2.25  PhysIOL's FineVision
2.2.26  IOL Research and New Lenses
2.2.27  ReSTOR Multifocal Toric AcrySof IQ
2.2.28  Abbott Tecnis One-Piece Toric
2.2.29  Lenstec Tetraflex
2.2.30  Calhoun Vision Light-Adjustable Lens
2.2.31  Abbott Visiogen Synchrony
2.2.32  Rayner M-flex T
2.2.33  NuLens DynaCurv
2.2.34  Carl Zeiss AcriLisa Diffractive Multifocal Toric
2.2.35  Bausch + Lomb’s Crystalens Toric
2.2.36  Hoya’s Adoptics
2.3 Intraocular Lens Market Forecasts
2.3.1 Intraocular Lens Market Segment Forecasts
2.3.2 Number of Cataract Surgeries Per Year
2.3.3 Novartis Positioning with Sales and Marketing Resource
2.3.4 Bausch + Lomb Small Incisions
2.3.5 Femtosecond Technology Is Game Changer
2.3.6 Intraocular Lens Unit Analysis
2.3.7 Aspheric Foldable IOL Lens
2.3.8 Intraocular Lens Presbyopia Market Forecasts
2.3.9 Market Trend:  Monofocal IOL Channel Will Be Slowly But Continuously Eroded By The Multifocal IOL
2.3.10  Presbyopia-Correcting Intraocular Lens (IOL)
2.3.11  Premium Channel Surgeons
2.3.12  Market Trend:  Accommodating IOL Channel to Grow
2.3.13  Market Trends:  Diffractive Lenses
2.3.14  Market Trend:  Multifocal IOLs
2.3.15  Market Trend:  Surgical Workstation
2.3.16  Premium IOL Forecasts
2.3.17  Technologies Driving Intraocular Lens IOL Market Growth
2.3.18  Diffractive IOLs
2.3.19  Large Middleclass Population Base Driving Intraocular Lens IOL Market Growth
2.3.20  Nonfoldable Polymethylmethacrylate/Plexiglas Based Lenses To Silicone And Acrylic Based Foldable Lenses
2.3.21  Global Vision Care and Ocular Market
2.4 Intraocular Lens Prices
2.4.1 Premium Lens Technology Reimbursement Trends
2.4.2 CMS Medicare Intorocular Reimbursement Guidelines
2.5 Intraocular Lens Regional Market
2.5.1 Eye Surgical Techniques by Country
2.5.2 United States
2.5.3 Canada
2.5.4 Brazil Cataract Surgical Procedure
2.5.5 Brazilian  Cataract surgeries
2.5.6 China
2.5.7 Toric Lens Implantations On The Rise In Europe
2.5.8 Advanced Technology Intraocular Lens Growth Markets
2.5.9 Cataract Surgery in the UK
2.5.10  Asia-Pacific Cataract Surgery
2.5.11  Cataract Surgery in India
2.5.12  Cataract Surgery Assembly Line Systemm Followed At Aravind Eye Hospitals
2.5.13  Aurolab’s Low-Cost, High-Volume Business Model
2.5.14  Highly Efficient Operations Coupled With Pricing Structure Allow 50% Profit Margin
2.5.15  World Health Organization (WHO),

3. Intraocular Lens (IOL) Product Description
3.1 IOL lenses
3.2 Novartis / Alcon
2.1.1 Novartis / Alcon
2.1.2 Novartis / Alcon Competitive Situation
2.1.3 Novartis / Alcon Competition
2.1.4 Novartis Alcon Multifocal Lenses
2.1.5 Novartis / Alcon
2.1.6 Novartis / Alcon
2.1.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.1.8 LenSx Acquired by Alcon
3.3 Abbott Medical Optics / Visiogen’s Synchrony
3.3.1 Abbott Medical Optics Synchrony
3.3.2 Abbott Medical Optics’
3.3.3 Abbott Medical Optics / Visiogen’s Synchrony Lens
3.4 Bausch & Lomb / Crystalens
3.4.1 Bausch & Lomb Crystalens AO Lens
3.4.2 Bausch + Lomb: Accommodating IOLs
3.4.3 Bausch + Lomb:  Crystalens IOL
3.4.4 Bausch & Lomb Crystalens HD
3.5 Calhoun Vision’s Light Adjustable Lens
3.6 NuLens
3.7 PixelOptics
3.8 Imperial Medical Technologies’
3.9 Presbia’s Flexivue
3.10 Lenstec’s Tetraflex Lens
3.11 Staar
3.11.1  STAAR® Surgical Company nanoFLEX IOL
3.11.2  Staar Elastimide® Silicone Aspheric IOL
3.11.3  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.4  Staar Afinity™ Collamer® Aspheric IOL
3.11.5  STAAR Toric™ IOL
3.11.6  Staar Afinity™ and nanoFLEX™ Collamer Aspheric IOLs
3.11.7  Staar Collamer Advantage
3.11.8  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.9  STAAR Surgical Elastimide Silicone Aspheric IOL Model AQ2015A
3.11.10  STAAR Elastimide Lens Model AQ2003V
3.11.11  STAAR Elastimide Lens Model AQ2010V
3.11.12  STAAR Elastimide Lens Model AQ5010V - Low Diopter
3.11.13  STAAR Elastimide Lens Model AQ2017V (Discontinued)
3.11.14  STAAR Elastimide Lens Model AQ1016V (Discontinued)
3.11.15  STAAR Elastic Lens Model AA4204VF
3.11.16  STAAR Elastic Lens Model AA4204VL
3.11.17  STAAR Elastic Lens Model AA4207VF (Discontinued)
3.11.18  STAAR Toric Silicone Single Piece IOL
3.11.19  STAAR Elastic Toric Lens Model AA4203TL
3.11.20  Canon-STAAR Preloaded IOL Model KS-3Ai
3.12 Lxenstec’s Tetraflex
3.12.1  Lxenstec’s Tetraflex Manufactured To A Tenth Of A Diopter Toleranc3-e
3.12.2  Lxenstec Elenza Lens
3.13 Hoya
3.14 Tecnis MF
3.14.1  PowerVision (Belmont, Calif.), Oculentis (Berlin), and PhysIOL (Liège, Belgium
3.14.2  PowerVision's FluidVision
3.14.3  FluidVision
3.15 MPlus by Oculentis
3.16 PhysIOL's FineVision
3.17 WaveTec Vision
3.18 Pediatric Cataract / Intraocular Lenses (IOL)
3.18.1  4 D change in power is needed between ages 10 and 20
3.18.2  Correcting Astigmatism in Pediatric Patients

4. Intraocular Lens (IOL) Technology
4.1 The Human Eye
4.2 Cataracts
4.2.1 Staar Collamer
4.2.2 Cataract Symptoms
4.2.3 Benefits Of Cataract Eye Surgery
4.2.4 How Cataract Eye Surgery Is Performed
4.3 Intraocular Tens Technology
4.3.1 Technologies Driving Intraocular Lens IOL Market Growth
4.4 Aspheric Contact Lenses
4.5 Refractive Disorders
4.6 Studies On The Restor Toric Lens
4.6.1 MNRead Functional Reading Test
4.7 Surgeons Need To Concentrate On Proper Patient Selection
4.8 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses
4.8.1 Obesity Cause of Diabetes and Neuropathy of the Eye

5. Intraocular Lens (IOL) Company Description
5.1 Abbott Laboratories
5.1.1 Abbott Acquired Visiogen with Synchrony Product
5.1.2 Abbott Labs Cataract Company Acquisitions
5.1.3 Abbott Completes Separation of Research-Based Pharmaceuticals Business
5.1.4 Abbott (NYSE: ABT) Separation Of Its Research- Based Pharmaceuticals Business
5.1.5 Abbott Separating Into Two Independent Companies
5.1.6 Abbott Laboratories and Subsidiaries Revenue
5.1.7 Abbott Sales Mix
5.1.8 Abbott Nutritional Market Presence
5.1.9 Abbott Diagnostics Market Presence
5.1.10  Abbott Medical Devices Market Presence
5.1.11  Abbott Strength Through Ability to Innovate
5.1.12  Abbott Revenue
5.1.13  Abbott Medical Optics
5.1.14  Abbott Medical Optics Corneal Products
5.1.15  Abbott Medical Optics Refractive Product Line
5.1.16  Abbott Medical Optics Cataract Products
5.1.17  Abbott Medical Optics Technological Innovation
5.2 Akkolens
5.2.1 AkkoLens Features
5.2.2 AkkoLens Clinical Partners
5.3 Allergan
5.3.1 Allergan Flagship Franchises In Eye Care, Neurosciences,Medical Dermatology And Urologics
5.3.2 Allergan Acquisition of Inamed Corporation
5.3.3 Allergan Specialty Product Lines Focused On High-Growth Markets
5.3.4 Allergan Global in reach. Specialized in focus
5.3.5 Allergan Leading Products
5.3.6 Allergan/  SkinMedica, Inc. Acquisition
5.3.7 Allergan Obesity Intervention
5.4 Aravind
5.4.1 Future of Aravind
5.5 Bausch And Lomb
5.5.1 Bausch + Lomb Vision Care
5.5.2 Bausch + Lomb Pharmaceuticals
5.5.3 Bausch + Lomb Cataract and Vitreoretinal Surgery
5.5.4 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.5 Bausch + Lomb Technolas® Perfect Vision
5.5.6 Bausch + Lomb Technolas® Perfect Vision Transforming Refractive Surgery
5.5.7 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.8 Technolas Perfect Vision
5.6 Biovision
5.7 Elenza
5.8 Kowa Company, Ltd.Environmental & Energy Saving Products
5.9 Hoya
5.9.1 Hoya, Seiko And Epson; Agreements Executed In The Field Of Optical Products Business
5.9.2 Hoya Second Quarter Revenue
5.10 Lenstec
5.11 Novartis Group / Alcon
5.11.1  Novartis Alcon Division
5.11.2  Novartis Revenue
5.11.3  Alcon Cataract Surgery
5.11.4  Alcon Surgical Glaucoma
5.11.5  Alcon Vitreoretinal
5.11.6  Alcon Refractive Surgery
5.11.7  Alcon Acquires Leading Ocular Surgical Guidance Technology
5.11.8  Alcon
5.11.9  Alcon Acquired The Ophthalmic Division of SensoMotoric Instruments (SMI)
5.11.10  Alcon Division Surgical Products
5.11.11  Alcon Ophthalmic Pharmaceuticals
5.11.12  Alcon Products
5.11.13  Alcon Cataract Reimbursement
5.11.14  Alcon Regulation
5.11.15 LenSx Acquired by Alcon
5.12 OptiMedica
5.12.1  Catalys next generation laser cataract surgery platform
5.13 Physiol
5.13.1  Physiol Multifocal IOL FineVision (Micro F) 2
5.14 Rayner
5.14.1  Surgery on 109 Year old Woman Using Rayner IOL
5.15 Staar Surgical
5.15.1  STAAR Surgical Devices Used In Corrective Surgery
5.15.2  STAAR Surgical Minimally Invasive Intraocular Lenses (IOLs).
5.16 WaveTec Vision®
5.16.1  WaveTec Vision Secures $16.5m To Market Cataract Surgery System
5.17 Zeiss –
5.17.1  Zeiss Vision
5.17.2  Zeiss Revenue
5.18 Selected Companies in the Market

List of Tables


Table ES-1 Intraocular Lens Market Driving Forces
Figure ES-2 Advanced Technology Intraocular Lens Growth Drivers
Table ES-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift.
Table ES-3 Intraocular Lens Market Challenges
Table ES-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Figure ES-5 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 1-1 Cataract Surgery Diverse Market Growth Drivers
Table 1-2 Intraocular Lens Market Challenges
Table 2-1 Intraocular Lens Market Driving Forces
Figure 2-2 Advanced Technology Intraocular Lens Growth Drivers
Table 2-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift
Table 2-3 Intraocular Lens Market Challenges
Table 2-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Table 2-5 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
Table 2-6 Novartis Cataract Surgical Techniques
Figure 2-7 Novartis / Alcon Overview of Surgical Franchise
Figure 2-8 Alcon Key Intraocular Lenses (IOLs) Products
Table 2-9 Novartis / Alcon IOL Market Strategic Positioning
Figure 2-10 Bausch + Lomb Crystalens® is an FDA-approved intraocular lens
Table 2-11 ReSTOR’s Acrylic Material Helps Keep It From Rotating Postop
Figure 2-12 Abbott Tecnis Toric IOL
Figure 2-13 Lenstec Tetraflex
Figure 2-14 Abbott Visiogen Synchrony
Figure 2-15 NuLens DynaCurv
Figure 2-16 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 2-17 Intraocular Lens Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-18 Low End Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Figure 2-19 Premium Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Table 2-20 Intraocular Lens (IOL) Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-21 Intraocular Lens (IOL), Market Forecasts, Units, Worldwide, 2013-2019
Figure 2-22 Novartis Franchise Dedicated Resources
Figure 2-23 Cataract Surgery Pathophysiology, Prevalence, and Surgical Techniques
Table 2-24 Intraocular Lens Description
Table 2-25 Intraocular Lens Advanced Technology
Figure 2-26 Novartis Commentary on Cataracts as Leading Cause of Reversible Blindness
Figure 2-27 Intraocular Lens (IOL) Regional Market Segments, Dollars,  2012
Table 2-28 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide, Dollars, Worldwide, 2013-2019
Table 2-29 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide Percent, Worldwide, 2013-2019
Figure 2-30 Eye Surgical Techniques by Country 
Figure 3-1 Novartis / Alcon Key Intraocular Lenses (IOLs) Products
Table 3-2 Novartis Cataract Surgical Techniques
Figure 3-3 Novartis / Alcon Overview of Surgical Franchise
Table 3-4 Novartis / Alcon IOL Market Strategic Positioning
Table 3-5 Abbott Medical Optics Cataract Products
Table 3-6 Abbott Medical Visiogen’s Synchrony lens Advantages
Table 3-7 Abbott Medical Visiogen’s Synchrony Lens Disadvantages
Figure 3-8 Bausch + Lomb Crystalens® FDA-Approved Intraocular Lens
Figure 3-9 Bausch + Lomb:  Crystalens IOL Features
Figure 3-10 STAAR® Surgical Company nanoFLEX IOL
Figure 3-11 Staar Implantable Collamer® Lens for Quality of Vision
Table 3-12 Staar IOL Products
Figure 3-12 Staar Toric Visual Acuity
Figure 3-13 Hoya Pre-Loaded IOL Delivery System “iSert™
Figure 4-1 Human Eye
Figure 4-2 Staar nanoFLEX
Figure 4-3 Staar nanoFLEX  Collamer has a built in Anti-Reflective Interface
Figure 4-4 Staar Hydrophilic Collamer Ultra-High Water Content Layer On Its Surface Minimizing The Difference In Refractive Index
Figure 4-5Staar nanoFLEX™ Collamer Percentage of Light Reflectance
Figure 4-6 Staar nanoFLEX™ Collamer Single Piece IOL
Figure 4-7 Staar nanoFLEX™ Collamer Incision Size
Figure 4-8 Staar nanoFLEX™ Collamer Protective Layer
Figure 4-9 Staar Afinity 3-Piece Collamer Aspheric IOL Model CQ2015A
Function 4-10 Modulation Transfer Function (MTF) Analysis
Table 4-11 Cataract Symptoms
Table 5-1 AkkoLens Technological Features
Table 5-2 AkkoLens Medical Features
Figure 5-3 Hoya IOL plant in Singapore
Figure 5-4 Novartis / Alcon Positioning in Healthcare
Figure 5-5 Novartis Resource By Segment
Figure 5-6 Novartis Surgical Franchise

List of Figures

NA

Upcoming Reports:

Wireless Gigabit (Wigig) Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 – 2018
By - Transparency Market Research
Wireless technology is in vogue at present. People have a huge preference for wireless devices because of its speed and convenience. The most recent innovation in wireless technology is Wireless Gigabit or WiGig. In simple terms WiGig is a wireless technology which operates in a wireless platform over the bandwidth of 60 Hz or more. WiGig is thus designed so as to facilitate faster communication and rapid data transmission. It also possesses more speed than WiFi.  WiGig also ensures high level security and accuracy in data transfer. The current market for WiGig technology...
Nanotechnology in Medical Equipment Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Nanotechnology has tremendous potential to reform the healthcare industry. It is expected that incorporation of nanotechnology in various applications of healthcare will be the major phenomenon to watch in the next decade. Thus nanotechnology in healthcare offers substantial opportunities to revolutionize the field of diagnosis, prevention and treatment of diseases. Increase in prevalence of chronic diseases, rising awareness about preventive measures of healthcare and large scale development in nanotechnology are the major drivers of this market. Incorporation of...
1, 3 Butadiene Market & Downstream Applications - Industry Analysis, Market Size, Share, Trends, Growth And Forecast, 2009 - 2018
By - Transparency Market Research
The world market for 1,3 butadiene is largely driven by demand for elastomers due to their extensive use in manufacture of tires. The global market for 1,3 butadiene was estimated at USD 22 billion for the year 2011, and is estimated to rise by 45.6% in the next 5 years and reach a market size of approximately 32 billion by year 2018. The demand for elastomers is expected to rise at a CAGR of 5.8% during 2012 – 2018, which in turn will drive the 1.3 butadiene market growth, growing at 6.5% during the same period. The market for butadiene, segmented on the basis of...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...